The test case centers on a nonprofit group’s Safehouse project in Philadelphia.
The nonprofit Safehouse had plans to open the first supervised injection site in the country where people could bring illegal opioids to inject under medical supervision.
Two pandemic peaks and one momentous election later, the case for Safehouse is resurfacing — this time in the U.S. Court of Appeals for the 3rd Circuit.
A bill that would effectively ban supervised injection sites in Philadelphia is steadily advancing with the apparent backing of all but two members of City Council.
In general, academic research does not support the claim that supervised injection sites lead to an increase in neighborhood crime or drug-dealing.
U.S. Attorney William McSwain has filed notice that he will appeal a judge’s ruling this week that found the plan legal.
In anticipation of a final court ruling that would clear the way for Safehouse — the nation’s first supervised injection site — to open, the City of Philadelphia has issued a public safety plan outlining how police will protect both those using the site and neighborhood residents.
